TrialAdvances in therapy2024

Ibrutinib Efficacy, Safety, and Pharmacokinetics in Chinese Patients with Relapsed or Refractory Waldenström's Macroglobulinemia: A Multicenter, Single-Arm, Phase 4 Study.

Shuhua Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.